| PERIOD ENDING | 31-Jul-02 | 30-Apr-02 | 31-Jan-02 | 31-Oct-01 | | Total Revenue | 22,860 | 19,886 | 18,418 | 22,817 | | Cost of Revenue | 20,716 | 16,763 | 14,683 | 23,665 | | | Gross Profit | 2,143 | 3,123 | 3,735 | (848) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,496 | 4,742 | 6,604 | 6,894 | | Non Recurring | 4,759 |
-
|
-
| 1,573 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,112) | (1,619) | (2,870) | (9,315) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 56 | 168 | (168) | (204) | | Earnings Before Interest And Taxes | (9,056) | (1,451) | (3,037) | (9,519) | | Interest Expense | 622 | 751 | 743 | 1,043 | | Income Before Tax | (9,678) | (2,202) | (3,781) | (10,562) | | Income Tax Expense | (90) | (1,690) |
-
| 325 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,587) | (511) | (3,781) | (10,887) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| (2,189) | | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,587) | (511) | (3,781) | (13,076) | | Preferred Stock And Other Adjustments | (125) | (462) | (628) |
-
| | | Net Income Applicable To Common Shares | ($9,712) | ($973) | ($4,408) | ($13,076) |
|
0.83% Nasdaq 0.00%
Income Statement
